a serious design defect that could interfere with demonstrating a benefit for treatment might arise from the fact that all patients in the grap and similarly designed studies had to show complex ventricular arrhythmias at randomization and that antiarrhythmic treatment was usually continued regardless of its effect on the underlying arrhythmias .
C0085612
ventricular arrhythmias
C0003811
arrhythmias